The de-regulation of ADAR-mediated RNA editing can promote cell transformation and tumor progression [18], and bioinformatic analyses combined with experimental studies have shown that ADAR-mediated editing patterns differ in normal and cancer tissues, including brain cancer, such as glioblastoma (GBM) [19,20,21]. The gene discussed is ADAR; the disease is glioblastoma.